GoKawiilNature issues correction to 2017 ME2 pancreatic cancer study over figure errors
Nature has published an author correction to a 2017 paper on genomic deletion of malic enzyme 2 (ME2) in pancreatic cancer, fixing several figure mistakes made during assembly. These include a duplicated AMPKα immunoblot image, an incorrect β-actin loading-control blot, and a mislabelled timepoint in bioluminescence imaging data.
GoKawiil's interpretation of the reporting above, not reported fact.
The corrections address technical mix-ups in image assembly rather than substantive scientific problems, and the authors state the underlying results and conclusions of the ME2 collateral-lethality research remain unchanged. Such corrections still matter for scientific transparency, as they show journals and authors actively auditing figures years after publication to maintain data integrity.
- A duplicated AMPKα blot and wrong β-actin image in the original figures have been replaced with correct versions from supplementary data.
- A bioluminescence imaging timepoint was mislabelled as 76 days instead of the correct 79 days.
- The authors confirm these figure-preparation errors do not change the study's scientific conclusions.
Source: nature.com — Dey, 2026-09-17
Published there as: “Author Correction: Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.